Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 28;12:759565. doi: 10.3389/fimmu.2021.759565

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Chen, Zhou, Liu and Zhang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

CTNNB1-MUT was associated with shorter PFS in HCC patients responding to ICI treatment. Univariable Cox regression analysis (A) and multivariable Cox regression analysis (B) in subgroups of mutation, sample type, HBV status, HCV status, and gender in the Harding-HCC cohort. Univariable Cox regression analysis (C) and multivariable Cox regression analysis (D) in subgroups of CTNNB1 mutation status, sample type, HBV status, HCV status, and gender in the Harding-HCC cohort. (E) Kaplan-Meier curves comparing the progression-free survival (PFS) of patients with CTNNB1-Mutant (CTNNB1-MUT) and patients with CTNNB1-wildtype (CTNNB1-WT) in the Harding-HCC cohort. (F) A Sankey diagram visualizing the clinical characteristics of CTNNB1-MUT and CTNNB1-WT patients in the Harding-HCC cohort.